Latest filing published 03 Jun 2021 for KalVista Pharmaceuticals, Inc., €165k.
Filing timeline
BuySaleInsider track record
Michael David Smith: trading record in brief
Michael David Smith is a declared insider of KalVista Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 28 April 2021 and the latest from 1 June 2021.
No open-market purchase appears, only 2 sales worth €377k. Outside the open market, there are 1 option exercise.
The record was last updated on 3 June 2021 with an open-market sale (€165k) in KalVista Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michael David Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,500 shares@ US$26.8333.1% of flowCommon StockSEC:0001209191-21-037889:1
- 10,014 shares@ US$8.3913.9% of flowCommon StockSEC:0001209191-21-029341:0
- 10,014 shares@ US$25.7642.7% of flowCommon StockSEC:0001209191-21-029341:1
3 of 3 declarations
